Company Performance - P3 Health Partners Inc. reported a quarterly loss of $0.15 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, and compared to a loss of $0.09 per share a year ago, indicating an earnings surprise of -87.50% [1] - The company posted revenues of $379.16 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 4.02%, and showing an increase from year-ago revenues of $329.09 million [2] - Over the last four quarters, P3 Health Partners has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - P3 Health Partners shares have declined approximately 57% since the beginning of the year, contrasting with the S&P 500's gain of 9.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $368.5 million, and for the current fiscal year, it is -$0.28 on revenues of $1.53 billion [7] Industry Outlook - The Medical Info Systems industry, to which P3 Health Partners belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The outlook for the industry can significantly impact the performance of P3 Health Partners' stock, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Tops Revenue Estimates